Clinical Genetics Department, Human Genetics and Genome Research Institute, National Research Centre, Cairo 12622, Egypt.
Oro-Dental Genetics Department, Human Genetics and Genome Research Institute, National Research Centre, Cairo 12622, Egypt.
Genes (Basel). 2023 Apr 12;14(4):900. doi: 10.3390/genes14040900.
gene mutations underlie osteopetrosis, a rare genetic disorder impacting osteoclast function with consequent brittle bones prone to fracture, in spite of being characterized by increased bone density. The disorder is known to exhibit marked genetic heterogeneity, has no treatment, and is lethal in most instances. There are reports of ethnic variations affecting bone mineral density and variants' expression as diverse phenotypes even within individuals descending from the same pedigree. We herein focus on one of osteopetrosis's three types: the autosomal recessive malignant form (MIM 259700) (ARO) that is almost always associated with severe clinical symptoms. We reviewed the results of about 1800 Egyptian exomes and we did not detect similar variants within our Egyptian dataset and secondary neurological deficit. We studied twenty Egyptian families: sixteen ARO patients, ten carrier parents with at least one ARO affected sib, and two fetuses. They were all subjected to thorough evaluation and gene sequencing. Our results of twenty-eight individuals descending from twenty Egyptian pedigrees with at least one ARO patient, expand the phenotype as well as genotype spectrum of recessive mutations in the gene by five novel pathogenic variants. Identifying gene mutations in Egyptian patients with ARO allowed the provision of proper genetic counseling, carrier detection, and prenatal diagnosis starting with two families included herein. It also could pave the way to modern genomic therapeutic approaches.
基因突变是导致成骨不全症(osteopetrosis)的原因,这是一种罕见的遗传性疾病,影响破骨细胞的功能,导致骨骼脆弱易碎,容易骨折,尽管其特征是骨密度增加。这种疾病表现出明显的遗传异质性,目前尚无治疗方法,大多数情况下是致命的。有报道称,种族差异会影响骨矿物质密度,即使是来自同一血统的个体,其变体的表达也会呈现出不同的表型。我们在此重点关注成骨不全症的三种类型之一:常染色体隐性恶性形式(MIM 259700)(ARO),这种形式几乎总是与严重的临床症状相关。我们回顾了大约 1800 个埃及外显子组的结果,在我们的埃及数据集中没有发现类似的变体,也没有发现继发性神经功能缺损。我们研究了二十个埃及家庭:十六个 ARO 患者,十个携带者父母,他们至少有一个 ARO 受累的兄弟姐妹,还有两个胎儿。所有这些人都接受了全面的评估和基因测序。我们对来自二十个埃及家系的二十八个人的研究结果,通过五个新的致病性变体扩展了 基因隐性突变的表型和基因型谱。在埃及 ARO 患者中鉴定出 基因突变,使得可以提供适当的遗传咨询、携带者检测和产前诊断,从包含在此处的两个家庭开始。它还可以为现代基因组治疗方法铺平道路。